ABSTRACT
Aims and Method To evaluate cardiovascular risk in a rural inpatient psychiatric unit over a one-year period. Care records were analysed for risk factor recording, and cardiovascular risks estimated using the QRISK3 calculator, which estimates 10-year risk of myocardial infarction or stroke.
Results Of eligible patients, risk factor recording as part of routine care was completed in 86% of possible QRISK3 inputs, enabling QIRSK3 estimation in all eligible patients. QRISK3 for this group was raised (Relative risk: 3.8, 95%CI: 2.5 – 5.0). High risk of cardiovascular disease (QRISK3 score >10%) was detected in 28% of patients.
Clinical Implications This service evaluation demonstrated significant unmet need for cardiovascular risk reduction that could be identified as part of routine care. An opportunity exists to integrate mental and physical healthcare by routinely assessing cardiovascular risk in psychiatric inpatients. Resources and training are needed to produce this risk information and act on it.
Competing Interest Statement
IB is Chief Data Scientist Advisor for AstraZeneca via the University of Liverpool Consult service, and AstraZeneca have a lipid-lowering therapeutic in their drug portfolio. There are no other authors with interests to declare.
Funding Statement
This study was supported by Health Care Research Wales via an NHS Research Time award to AW (NHS Wales RTA 21-02).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Powys Teaching Health Board gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
